Werbung
Werbung
KURA
Kura Oncology, Inc.
9.39
USDGesponsert
-0.16
-1.64%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
9.49
+0.10
+1.09%
KURA Ergebnisberichte
Positives Überraschungsverhältnis
KURA übertreffen die 31 der letzten 40Schätzungen.
78%
Nächster Bericht
Datum des nächsten Berichts
24. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$85.60M
/-$0.41
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+312.51%
/-51.76%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+58.85%
/+86.36%
Kura Oncology, Inc. earnings per share and revenue
On 04. Nov. 2025, KURA reported earnings of -0.85 USD per share (EPS) for Q3 25, beating the estimate of -0.86 USD, resulting in a 2.16% surprise. Revenue reached 20.75 million, compared to an expected 42.08 million, with a -50.69% difference. The market reacted with a +1.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analysts forecast an EPS of -0.41 USD, with revenue projected to reach 85.60 million USD, implying an decrease of -51.76% EPS, and increase of 312.51% in Revenue from the last quarter.
FAQ
What were Kura Oncology, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Kura Oncology, Inc. reported EPS of -$0.85, beating estimates by 2.16%, and revenue of $20.75M, -50.69% below expectations.
How did the market react to Kura Oncology, Inc.'s Q3 2025 earnings?
The stock price moved up 1.94%, changed from $9.77 before the earnings release to $9.96 the day after.
When is Kura Oncology, Inc. expected to report next?
The next earning report is scheduled for 24. Feb. 2026.
What are the forecasts for Kura Oncology, Inc.'s next earnings report?
Based on 16
analysts, Kura Oncology, Inc. is expected to report EPS of -$0.41 and revenue of $85.60M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung